Medkart pitches generic medicine app as cheaper alternative to branded drugs

Medkart says its app is helping Indian families cut medicine costs with generic price comparisons, prescription matching and hybrid delivery across 35,000-plus pin codes. The push comes as high out-of-pocket spending and low trust in generics continue to limit access to affordable care in India.

Why it matters: - India still has heavy out-of-pocket health spending, which makes monthly medicine bills a major burden for families with chronic diseases. - Medkart is targeting that pain point with a digital-first generic medicines platform built around lower prices, easier access and more transparency. - The company’s model is aimed at patients who delay care or pay for costlier branded drugs because they do not know cheaper generic options are available.

What happened: - Medkart presented its app as a generic medicine shopping platform designed to help users compare prices, find substitutes and place orders more easily. - The company said the platform is built for patients in India, with a focus on chronic conditions and harder-to-serve tier-2 and rural markets. - Medkart said the app is available in Hindi, English and Gujarati.

The details: - Medkart’s generic medicine comparison engine lets users compare prices and compositions instantly. - The company cited voriconazole as an example, saying the medicine can drop from Rs. 5,192 to Rs. 720 on Medkart, a savings of up to 86%. - The app organizes medicines into disease buckets including diabetes, blood pressure, kidney and heart conditions. - Users can upload prescriptions, and the app matches them with “Medkart Assured” generics. - Medkart says those generics are tested for Schedule M compliance and plant-audited. - The app includes WhatsApp ordering, which Medkart says is designed to reduce digital barriers for older and rural users. - Medkart uses a hybrid model that combines online delivery with 100-plus retail stores. - The company says it covers more than 35,000 pin codes and supports cash-on-delivery plus multiple payment options. - Medkart says it has saved customers Rs. 650 crore, fulfilled 60 lakh orders and served 11-plus lakh families. - The company also points to nearly 600 million WhatsApp users in India as part of the case for its ordering model.

Between the lines: - Medkart is trying to solve two problems at once: price confusion and trust in generics. - The company is also betting that convenience matters as much as price, especially for chronic patients who need repeat monthly purchases. - Its hybrid store-and-delivery setup suggests Medkart wants to compete beyond a pure app experience and reach customers who still prefer local pharmacy support.

What’s next: - Medkart is positioning itself to ride the broader shift toward generic medicines and digital health adoption in Tier 2 and Tier 3 cities. - The company is leaning on transparent pricing and disease-specific discovery to win more users who are still buying branded medicines by default. - Medkart says the app is meant to help patients switch to generics without sacrificing quality or convenience.

The bottom line: - Medkart is pitching itself as more than a pharmacy app: it is trying to become a lower-cost medicine platform for India’s chronic-care patients.